Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy

BACKGROUND: Previous studies support the effectiveness of sesame oral immunotherapy (S-OIT) in patients >4 years old using maintenance doses of 1200 mg protein. However, tahini is often not palatable to children, and high-maintenance doses may not be possible for preschoolers. OBJECTIVE: We studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Gilbert T., Soller, Lianne, Kapur, Sandeep, McHenry, Mary, Rex, Gregory A., Cook, Victoria E., Cameron, Scott B., Chan, Edmond S., Yeung, Joanne, Erdle, Stephanie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616424/
https://www.ncbi.nlm.nih.gov/pubmed/37915725
http://dx.doi.org/10.1016/j.jacig.2023.100171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616424/
https://www.ncbi.nlm.nih.gov/pubmed/37915725
http://dx.doi.org/10.1016/j.jacig.2023.100171

Ejemplares similares